Viernes, 21 Julio 2023
Study reviews variability in white blood cell count in patients uncomplicated malaria
A new WWARN study, which looked at the variability in white blood cell (WBC) count in patients with uncomplicated malaria, found that using the assumed value of WBC in the calculation of parasite density led to a significant underestimation of parasite count for children and potentially sub-optimal ...
Jueves, 22 Junio 2023
CDISC compliant case report forms for uncomplicated VL and VL-HIV co-infection: A unique collaborative effort by VL experts and a first in NTDs
A global collaboration of the visceral leishmaniasis (VL) community has developed freely available, annotated case report forms (CRF) to accelerate research both into uncomplicated VL and specifically for patients with HIV-VL co-infection. The CRFs allow the collection of research-related data in a ...
Jueves, 15 Junio 2023
New project to collaboratively assess the drivers of recrudescent and persistent trachoma
While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for ...
Lunes, 22 May 2023
Tribute to Professor Dominic Kwiatkowski
We are very sad to share news of the death of Professor Dominic Kwiatkowski. He was the Director of the Centre for Genomics and Global Health, and held a joint position as MRC Clinical Research Professor at Oxford University, and as a Principal Investigator at the Wellcome Trust Sanger Institute.
Jueves, 27 Abril 2023
IDDO at CUGH: connecting with the global health community
Matt Brack, IDDO’s Senior Programme Manager, recently presented on our equitable approach to data collaborations in global health research at the Consortium of Universities for Global Health Conference (CUGH) in Washington, DC.
Martes, 25 Abril 2023
After reviewing progress on improving global medicine quality, participants plan next global conference
Last month, experts in medicine quality and substandard and falsified (SF) medicines gathered in Oxford for an informal one-day meeting following the workshop ‘The relationship between substandard and falsified antimicrobials and antimicrobial resistance and patient outcomes’.
Viernes, 14 Abril 2023
WWARN is part of a new consortium tackling malaria drug resistance in South-East Africa
A new consortium MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) launches today, responding to a growing crisis in malaria, one of the greatest infectious challenges facing Africa.
Viernes, 24 Marzo 2023
Study finds almost two-thirds of patients are systematically excluded from drug trials
A new WWARN study has found that nearly two-thirds of the malaria-positive patients who present to health facilities are systematically excluded from "classical" anti-malarial treatment efficacy trials.
Miércoles, 15 Marzo 2023
World Economic Forum blog on IDDO
We work with researchers in disease-affected communities to address their key priorities and improve patient outcomes. IDDO shares knowledge, delivers collaborative analyses, and ensures academic recognition for all data contributors. The World Economic Forum recently blogged on our work. "There are...
Miércoles, 1 Marzo 2023
You can now view the recording of our webinar - Radical cure of vivax malaria: can we do better?
The three presentations and expert discussion, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available on our YouTube channel @IDDOandWWARN. You can watch the full, partially captioned event here. ...
Viernes, 27 Enero 2023
Reminder: 3 February webinar on vivax malaria - there's still time to sign up
Two new studies using WWARN-hosted clinical trial data show that the dosing of the 8-aminoquinoline drugs primaquine and tafenoquine can be substantially improved. These analyses include the majority of all studied vivax malaria patients who received 8-aminoquinoline drugs over the last 20 years. La...
Viernes, 20 Enero 2023
IDDO’s latest newsletter is out
Read more about what we’ve been up to in our latest newsletter. There are updates on our research across COVID-19, malaria, medicine quality, febrile illness, Visceral leishmaniasis and you can sign up for our February 3 webinar - Radical cure of vivax malaria: can we do better?
Miércoles, 4 Enero 2023
Pilot study detects diverse DNA in ingredients of falsified tablets
A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.
Lunes, 19 Diciembre 2022
WWARN's latest newsletter is out
Find out more about what we've been up to in our latest newsletter. You'll find all of our news including our recent collaborative meta-analysis, commissioned by the WHO, which informed a change to its guidelines for treating uncomplicated malaria in the first trimester of pregnancy.